Danaher Stock (NYSE:DHR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$183.63

52W Range

$160.93 - $242.80

50D Avg

$180.82

200D Avg

$204.87

Market Cap

$127.96B

Avg Vol (3M)

$4.56M

Beta

0.83

Div Yield

$1.36 (0.75%)

DHR Company Profile


Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

61,000

IPO Date

Dec 29, 1978

Website

DHR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Revenue from Contract with Customer, Measurement, Recurring$20.13B$19.37B$18.68B
Revenue from Contract with Customer, Measurement, Nonrecurring$4.44B$4.51B$5.21B

Fiscal year ends in Dec 25 | Currency in USD

DHR Financial Summary


Dec 25Dec 24Dec 23
Revenue$24.57B$23.88B$23.89B
Operating Income$5.14B$5.18B$5.28B
Net Income$3.61B$3.90B$4.76B
EBITDA$6.95B$7.28B$7.50B
Basic EPS$5.07$5.33$6.44
Diluted EPS$5.04$5.29$6.38

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Apr 21, 26 | 8:00 AM
Q4 25Jan 28, 26 | 8:00 AM
Q3 25Oct 21, 25 | 1:00 AM

Peer Comparison


TickerCompany
MDTMedtronic plc
BSXBoston Scientific Corporation
ISRGIntuitive Surgical, Inc.
GILDGilead Sciences, Inc.
SYKStryker Corporation
TMOThermo Fisher Scientific Inc.
MCKMcKesson Corporation
AMGNAmgen Inc.
PFEPfizer Inc.
SNYSanofi